Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

113.27
BATS BZX Real-Time Price
As of 2:01pm ET
 +0.58 / +0.51%
Today’s Change
81.79
Today|||52-Week Range
115.00
+10.27%
Year-to-Date
JNJ Regular Dividend: JNJ began trading ex-dividend on 05/20/16. A $0.80 dividend will be paid to shareholders of record as of 05/24/16.
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
May 23 / MotleyFool.com - Paid Partner Content
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
May 24 / Zacks.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
5 Smart IRA Moves You Can Make Now
May 24 / MotleyFool.com - Paid Partner Content
Triple-A quality fades as companies embrace debt
May 23 / FT.com - Paid Partner Content
4 Dow Members Bucking the Negative Trend
May 24 / Zacks.com - Paid Partner Content
'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market
May 22 / GuruFocus News - Paid Partner Content
3 Stocks With Better Dividends Than Johnson & Johnson
May 24 / MotleyFool.com - Paid Partner Content
The 3 Best Retirement Funds for Your 401(k)
May 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close112.69
Today’s open113.23
Day’s range112.88 - 113.72
Volume261,895
Average volume (3 months)8,682,553
Market cap$310.0B
Dividend yield2.83%
Data as of 2:01pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-3.86%
Earnings growth (this year)+6.43%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-5.56%
P/E ratio20.7
Price/Sales4.12
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.23+0.66%
NVSNovartis+1.48+1.89%
AGNPRAAllergan plc-2.02-0.24%
MRKMerck+0.79+1.42%
Data as of 2:45pm ET, 05/25/2016

Financials

Next reporting dateJuly 12, 2016
EPS forecast (this quarter)$1.68
Annual revenue (last year)$70.2B
Annual profit (last year)$15.4B
Net profit margin21.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts

Partner Offers

Search for Jobs